NFP Ground Control acquires accountancy practice Clay GBP
Ground Control Business Management, part of NFP, has entered the UK with the acquisition of Clay GBP.
Established in 2014, Clay GBP offers accounting, taxation, and business advisory services, through its offices in London and the Midlands.
It also offers management services for bookkeeping, bill payments, and tax preparation and planning.
Additionally, Clay GBP facilitates estate planning, wealth management, and insurance services by coordinating with external resources.
NFP intends to integrate Clay GBP into Ground Control's operations, renaming it as Ground Control.
Clay GBP partners Richard Smethurst, Nick Parkinson, Bhavini Ratan, Ian Bailey, James Plumbly, Jasdeep Sami, and Philip Hampson will move to Ground Control, taking on the roles of managing directors.
They will report to Ground Control CEO Chris Bucci.
Bucci said: 'After partnering with Clay GBP for years, we're thrilled to welcome their team to NFP and expand our broad range of specialised business services internationally.
'Ground Control was started as a traditional US entertainment business management firm, and with our clients' global needs growing it made sense to add Clay GBP's tax and accounting expertise to our capabilities.
'Clay GBP's mission – which focuses on building relationships based on understanding and trust – aligns well with ours, and we look forward to collaborating for the benefit our existing clients and the broader industry.'
Smethurst and Parkinson added: 'We couldn't be happier to join NFP and become part of Ground Control, one of the most prominent firms in the business management services industry.
'NFP's breadth of expertise and capabilities across risk, human capital, wealth and retirement will give us an uplevelled approach to client relations and offerings for the UK.
'We're honoured to be a part of Ground Control's international expansion and bring US-style business management services to the UK market.'
"NFP Ground Control acquires accountancy practice Clay GBP" was originally created and published by International Accounting Bulletin, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Stablecoin issuer Circle soars in public market debut
Shares of stablecoin issuer Circle soared in its NYSE debut today, a validation of crypto's newfound importance to the American financial system and a symptom of investors starved for new issuances during a long IPO drought. Trading in the stock was halting just seconds after it began after the stock, which had been sold last night to IPO investors for $31 a share, opened at $69 and soared to nearly $76. The $31 price was below where Circle was previously valued by private investors. In an interview off the NYSE trading floor with Semafor, CEO Jeremy Allaire said he worried that if the US doesn't create a trusted and useful digital dollar — something his company's main product, USD Coin, aims to be — it might lose the 'digital currency space race' to China, which has a formidable lead over the US with its digital yuan. 'The digital dollar should be the highest utility money in the world,' he said. 'We are believers in the strength and continued preeminence of the dollar in the global financial system, and in the internet financial system that's being built up.' It's the digital version of a broader debate about the future of the dollar, as the global economy fractures under trade and geopolitical tensions. It's also a politically expedient play for Allaire's company, which, as the Financial Times notes, is quite exposed to the whims of central banks. A rival stablecoin issuer, Tether, has also latched onto the US-China rivalry. Liz Hoffman: The House passed stablecoin legislation. What's your expectation for what happens in the Senate? Jeremy Allaire: The GENIUS Act had a bipartisan supermajority to get it to where it is, and we believe it's an excellent piece of legislation. This is part of an effort by policymakers and governments around the world to integrate stablecoins as an M1-like electronic money type in the financial system. It represents a tremendous opportunity to have more companies, more financial institutions, more technology firms, build on this breakthrough technology. Do you expect competition from the Trump family? Circle has always faced competition. The position we've been able to build as a licensed, regulated, global firm — we think those remain strengths, and we're very comfortable that we're going to continue to be the leader. Becoming a public company is significant in terms of enhancing trust, transparency, and accountability. Crypto is right on the cusp of going mainstream, but is still shot through with fraud and criminal-adjacent actors. Do you think you can fully drag it into the sunlight? We aren't focused on speculative trading or different types of digital assets. We're trying to improve the financial system by building a new, electronic form of the dollar, and ultimately other fiat electronic money, to make the global economic system more fair and integrated. We saw, in the birth and growth of the internet, a huge range of things that people thought were useful — some of which became fundamental to all of our lives and some of which don't exist anymore. Do you worry that if the US doesn't become the backbone of that global digital infrastructure that someone else, maybe the Chinese, will? I do. The digital dollar should be the highest utility money in the world. We're trying to cement in law a framework that assures that the United States … can win the digital- currency space race. We are believers in the strength and continued preeminence of the dollar in the global financial system, and in the internet financial system that's being built up. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
43 minutes ago
- Yahoo
Elastomeric Infusion Pumps Market Set to Reach Valuation of US$ 1,357.40 Million By 2033
Demand for elastomeric infusion pumps is accelerating on clinician convenience, home-care growth, sustainable materials innovation, and regulatory harmonization, while digital supply chains and service ecosystems sharpen competition, driving product customization and regional adoption momentum. Chicago, June 05, 2025 (GLOBE NEWSWIRE) -- The global elastomeric infusion pumps market was valued at US$ 741.56 million in 2024 and is expected to reach US$ 1,357.40 million by 2033, growing at a CAGR of 7.85% during the forecast period 2025–2033. Bedside nursing teams cite speed and simplicity as decisive factors when selecting analgesic and antibiotic delivery devices. Unlike electronic programmable options requiring multistep calibration, disposable balloon pumps arrive pre-filled and ready within seconds, freeing clinicians during peak rounds. In the United States alone, more than forty-two thousand postoperative pain-management cases in 2023 relied on such devices, according to Premier's hospital supply database. European day-case surgery centers report a mean five-minute reduction in discharge preparation time per patient. These operational savings, multiplied across high-throughput facilities, form a powerful demand engine within the elastomeric infusion pumps market, particularly as staffing shortages intensify worldwide. Request Sample Pages: Patient autonomy is an equally potent catalyst. A British Pain Society audit involving 300 participants recorded 261 individuals walking unaided to bathrooms while on elastomeric devices, whereas only 129 managed the same action when tethered to electronic pumps. This freedom translated into six fewer breakthrough-analgesia doses per case at Seoul's Samsung Medical Center. Under value-based reimbursement, administrators monitoring readmission penalties treat mobility as a fidelity metric, thereby amplifying interest in the elastomeric infusion pumps market. Rural outreach programs in Canada now bundle balloon pumps with telehealth follow-ups, proving cost-effective despite harsh winter logistics. Expanded drug-specific home-use labeling expected in 2024 will further accelerate the global elastomeric infusion pumps market. Key Findings in the Elastomeric Infusion Pumps Market Market Forecast (2033) US$ 1,357.40 million CAGR 7.85% Largest Region (2024) North America (38.24%) By Product Type Continuous Rate Elastomeric Pumps (65%) By Application Pain Management (40%) By End Users Hospitals (44%) By Distribution Channel Direct Sales (B2B) (40%) Top Drivers Growing preference for home-based chemotherapy and pain management solutions Rising geriatric population requiring continuous medication delivery for chronic conditions Cost-effectiveness compared to electronic pumps reducing healthcare facility expenses Top Trends Integration of antimicrobial coating technologies in pump manufacturing for safety Shift towards larger reservoir capacities accommodating extended therapy duration requirements Adoption of multi-rate flow controllers enabling flexible dosing without replacement Top Challenges Limited flow rate adjustability compared to programmable electronic infusion pumps Temperature sensitivity affecting drug stability during prolonged ambulatory use periods Disposal concerns regarding non-recyclable elastomeric materials impacting environmental sustainability goals Material Science Innovations Elevating Precision And Extending Drug Stability Durations Recent advances in thermoplastic elastomers and multilayer silicone composites are pushing pressure consistency to unprecedented tolerances. In 2024, Japanese supplier Zeon Medical commercialized a proprietary styrene-isoprene block copolymer that keeps pressure deviation within ±3 mm Hg over a twelve-hour infusion. During validation at the Cleveland Clinic, the material delivered vancomycin with less than two milligrams cumulative variance, outperforming legacy latex balloons by a factor of four. Low residual drug volumes mean antimicrobial-stewardship committees can tighten dosing protocols, reducing the need for top-up syringes. Such precision is fast becoming a differentiator within the elastomeric infusion pumps market, especially as oncology pharmacies formulate high-cost monoclonal cocktails that cannot tolerate wastage in today's reimbursement-constrained hospital environment. Extended stability is the second material frontier. New ethylene-vinyl-acetate liners infused with UV blockers preserve light-sensitive chemotherapy compounds for up to twenty-four hours at ambient temperatures, according to a 2024 multicenter study led by France's Institut Curie. Pharmacies report that longer beyond-use dating halves the number of evening batch preparations, releasing staff for clinical-validation tasks. Importantly, the environmental profile is improving as well. Baxter's latest pump range now incorporates biobased thermoplastics certified under the USDA BioPreferred Program, cutting fossil-resin consumption by ten metric tons per million units. As hospital sustainability dashboards gain executive visibility, these advances strengthen vendor positioning within the elastomeric infusion pumps market. Regulatory Harmonization Streamlining Approvals While Raising Postmarket Surveillance Expectations Globally The regulatory scene for disposable infusion devices has shifted since the U.S. FDA reclassified elastomeric pumps to Class II with special controls in late 2023. The update introduced clearer consensus standards—ISO 28620:2021 for volumetric accuracy and ISO 80369-7 for connector integrity—allowing manufacturers to pursue the 510(k) pathway without separate clinical trials for every flow-rate variant. Health Canada followed suit within six months, referencing identical benchmarks. Harmonization compresses certification timelines; consultancy Emergo notes dossier review periods falling from twenty-three to eleven weeks. For hospital buyers, faster iteration loops mean field feedback—such as flow deceleration during altitude changes—can be rectified within the same fiscal year across the elastomeric infusion pumps market. However, streamlined entry is counter-balanced by stricter postmarket vigilance across the elastomeric infusion pumps market. Under Europe's Medical Device Regulation, manufacturers must submit Periodic Safety Update Reports summarizing complaint trends, adverse events, and corrective actions each calendar year. The first wave of submissions in 2024 revealed 94 micro-leak events at luer joints out of 282 adverse device incidents logged on EUDAMED, prompting regulators to recommend crimp-torque audits during production. Simultaneously, China's National Medical Products Administration expanded its unique-device-identification pilot to cover elastomeric pumps distributed in Guangdong Province, enabling barcode-driven recalls in under forty-eight hours. These converging policies elevate transparency, a factor seasoned group-purchasing organizations cite when ranking bidders in the elastomeric infusion pumps market. Regional Patterns Highlight Asia-Pacific Momentum And North American Homecare Leadership Asia-Pacific is currently the fastest-expanding theater for disposable balloon devices, propelled by government initiatives targeting treatment equity outside megacities. India's Pradhan Mantri Jan Arogya Yojana insurance scheme reimbursed an estimated ninety-five thousand elastomeric pump-based antibiotic courses during 2023, nearly doubling the prior year's tally. Meanwhile, Japan's revision of its Diagnosis Procedure Combination in April 2024 introduced an add-on payment for outpatient continuous analgesia, immediately lifting device volumes among regional hospitals like Kobe City Medical Center. Multilingual training apps developed by Australian vendor Avanos support this uptake by covering Mandarin, Hindi, and Bahasa tutorials, reducing setup errors in outreach clinics. Collectively, these elements cement the elastomeric infusion pumps market footprint across Asia. Contrastingly, North America exemplifies maturity through home-care specialization. Over six hundred licensed infusion pharmacies in the United States now integrate automated fill-and-crimp stations dedicated to elastomeric formats, according to the National Home Infusion Association's 2024 census. Canadian provinces are following suit; Ontario's public formulary added elastomeric devices for cystic-fibrosis antibiotics in February 2024, triggering an increase in provincial tenders for ancillary gravity sets from 1,200 to 1,680 line items. The commercial environment is consequently shifting from product introduction to service differentiation. Providers such as Option Care Health bundle same-day courier, remote temperature logging, and twenty-four-seven nurse chat. By aligning with hospital discharge planners, they keep average length of stay below four days, reinforcing economic arguments that sustain the elastomeric infusion pumps market in North America. Supply Chain Digitalization Enhancing Traceability, Reducing Waste, Ensuring Reliable Deliveries The single-use nature of balloon pumps creates complex inventory dynamics; missing a shipment can delay multiple oncology cycles. Recognizing this, manufacturers and distributors are adopting GS1 DataMatrix barcodes paired with cloud dashboards. In 2024, Cardinal Health extended its WaveMark platform to capture lot, fill date, and flow rate in real time as cartons leave contract sterilizers. Pilot hospitals such as Mayo Clinic–Rochester reported a ninety-minute reduction in receiving processes and flagged two cold-chain breaches before items reached pharmacy shelves. By automating these touchpoints, the elastomeric infusion pumps market is converging with pharmaceutical-serialization frameworks previously reserved for oral solids. This harmonization also helps states comply with impending Drug Supply Chain Security Act milestones. Predictive logistics is the next frontier. DHL Supply Chain's Life Sciences division now feeds anonymized hospital-consumption data into machine-learning models that forecast demand by National Drug Code and flow-rate combination two weeks ahead. Early results across nine U.S. regions show back-order incidents dropping from twelve to three per quarter. Manufacturers benefit as well; smoother demand curves optimize ethylene-oxide sterilizer slots, historically a bottleneck after pandemic PPE prioritization. Simultaneously, environmental objectives are met through better container utilization; one DHL lane between Singapore and Sydney eliminated seven flights in the first half of 2024. These wins collectively reinforce customer loyalty inside the elastomeric infusion pumps market while aligning it with global sustainability imperatives. Patient-Reported Outcomes Underscore Comfort, Mobility, And Improved Therapy Adherence Levels Evidence directly from users is vital to satisfy Google's Experience pillar. A multicountry observational study published in Pain Practice in February 2024 followed six hundred orthopedic patients discharged with either elastomeric pumps or electronic ambulatory devices. Using the validated PROMIS Physical-Function scale, the elastomeric cohort recorded a median score of sixty-three at day three post-surgery, compared with fifty-seven in the control group. Moreover, activity trackers supplied by Garmin showed an average of two thousand additional steps. Researchers attribute the gap to lower device weight and absence of alarms that might disrupt sleep. These findings reveal tangible lifestyle benefits not always captured by traditional efficacy endpoints. Adherence metrics further validate patient preference. Cleveland-based MetroHealth monitored line-flushing compliance among outpatient endocarditis patients using Bluetooth caps attached to pump outlets. Over a four-week episode, the elastomeric group registered ninety-two flushing events out of a planned ninety-six, while the electronic-pump group recorded seventy-eight. Pharmacists estimate that every missed flush risks lumen occlusion, which can add two inpatient days per incident. Consequently, insurers collaborating with health systems are piloting incentive models such as waived copays for patients choosing the disposable modality. This value cascade enhances stakeholder conviction, feeding back into hospital purchasing cycles and strengthening the elastomeric infusion pumps market by demonstrating measurable clinical-economic synergy within the broader elastomeric infusion pumps market ecosystem. Modify Report as Per Requirements: Future Outlook Emphasizes Sustainability, Customization, And Integration With Smart Ecosystems Looking toward 2025 and beyond, sustainability pressures will reshape design choices. Hospitals participating in Practice Greenhealth's annual survey now rank device recyclability alongside clinical performance when updating formularies. In response, German manufacturer Vygon is developing a pilot take-back scheme that sterilizes and repurposes spring clamps, aiming to divert forty metric tons of stainless steel from landfills annually. Concurrently, bio-derived polybutylene succinate balloons, currently in prototyping at the University of Massachusetts Lowell, promise full compostability in industrial facilities. Should these materials clear durability hurdles, they could shift brand loyalty dramatically within the elastomeric infusion pumps market, rewarding early movers that invest in circular supply loops. Environmental credits traded on voluntary carbon exchanges may further sweeten economics. Customization and connectivity will also command attention. Already, OncoDesign Paris is collaborating with Qualcomm to embed ultra-low-power NB-IoT chips that transmit residual volume every thirty minutes, granting caregivers granular adherence dashboards without compromising disposability. Modular flow restrictors are another frontier; pharmacies could stock a single balloon size and attach sterile snap-on disks calibrated for rates from three to twenty milliliters per hour, slashing SKU counts. Integration with electronic health records is advancing in tandem, as HL7 FHIR profiles for disposable pumps enter ballot at Health Level Seven International. Together, these developments foreshadow a more responsive elastomeric infusion pumps market, ultimately enriching patient outcomes and operational resilience across the global elastomeric infusion pumps market. Global Elastomeric Infusion Pumps Market Major Players: B. Braun Melsungen AG Baxter International Inc. Terumo Corporation Smiths Medical (now part of ICU Medical) Fresenius Kabi Leventon (a Werfen company) Nipro Corporation Canè S.p.A. Other Prominent Players Key Market Segmentation: By Product Type Continuous Rate Elastomeric Pumps Variable Rate Elastomeric Pumps By Application Pain Management Chemotherapy Antibiotic/Antiviral Therapy Others By End Users Hospitals Ambulatory Surgical Centers (ASCs) Home Care Settings By Distribution Channel Direct Sales (B2B) Distributors / Wholesalers Retail Pharmacies & Medical Device Stores Online Sales / E-commerce Platforms By Region North America Europe Asia Pacific Middle East & Africa (MEA) South America Request Additional Details Before Purchase: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
an hour ago
- Yahoo
New owner of Portsmouth events venue once went to school there
Giovanni Donatelli used to walk the halls of Portsmouth Catholic High School as a young boy. Now, almost four decades later, Donatelli is the new owner of the renovated and renamed building, Cambridge Hall. An entrepreneur who moved to the U.S. in 1982, Donatelli is the founder and CEO of The Language Group, a Virginia Beach-based translation service company established in 1999. His company employs 70 fulltime employees and 600 linguists skilled in 225 languages. The Language Group also has a secondary office in Hamburg, Germany. In early April, Donatelli purchased the building at auction for $660,000. There was also a separate transaction totaling $25,000 to buy the intellectual property rights for the business, including the event hall, website, furniture, artwork and baby grand piano. William J. 'Billy' Summs Sr., auctioneer with Atlantic Asset Management Group, said Donatelli was the perfect buyer. The Italianate-style building was transformed into a wedding and event venue in 2022 by Ed O'Neil, an insurance agent with New York Life in Norfolk. Donatelli plans to reopen it this summer as an event hall to host family and company functions. An immigrant from the east coast of Italy, he said he identifies as a local boy from Portsmouth and cherishes the building. 'I stood where my locker used to be and you can see where the desks used to sit,' he said. 'I can almost see myself sitting in the classrooms again.' Armed with ideas, Donatelli said he will continue to operate it as a rental event hall for now — including employee functions for his business — but he is also thinking about using part of the more than 6,000 square feet for nonprofits. Overjoyed with the amount of care the two most recent owners put into the building following years of neglect, Donatelli, a resident of Virginia Beach, said it's now up to him to be a proper steward of it. 'I would love to have a reunion to celebrate the different classes that graduated from there — back in their own building,' he said. 'And I'd like to make a wall to honor the school with a copy of all the yearbooks.' Situated at the corner of London and Washington streets in Old Towne Portsmouth since 1892, the structure was originally St. Paul's Academy for Boys, then St. Paul's Catholic High School before it became Portsmouth Catholic High School in 1964. The Donatelli family's journey to Hampton Roads began in the late 1970s when his father, Otero, a tailor in his native land, was recruited by Morris Rapoport, late patriarch and founder of The Quality Shops. 'They couldn't find anyone in the U.S. so they extended their search and found my father,' Donatelli said. Rapoport sponsored the family's visas and after 6 years they applied for their citizenship. Donatelli's mother, Grace is known throughout Hampton Roads for her seamstress skills. Donatelli and his younger brother, Sandro began their schooling at the now defunct Shea Terrace Elementary where he fondly remembers they learned to speak English. His love of languages only grew from that experience. When Donatelli was in seventh grade, he started his studies at Portsmouth Catholic. An altar boy in Italy, Donatelli said he continued his faithful service to the church every Sunday, serving mass at St. Paul's Catholic Church adjacent to the school. 'I used to play right there and fly my kite on North Street in the parking lot,' Donatelli said. 'It's my home; even though I'm an immigrant, I really grew up in Portsmouth.' Portsmouth Catholic shuttered in 1991 and Donatelli graduated from Churchland High School the following year. 'It feels right; the sentimental connection is there, and it's really special that I was able to do this,' he said. 'It's really nice to feel like I can offer something back to the community by buying my old schoolhouse.' Sandra J. Pennecke, 757-652-5836,
